Cyanide is a toxic chemical that may be introduced into living organisms as a result of natural processes and/or anthropogenic uses (legal or illicit). Exposure to cyanide can be verified by analysis of cyanide or one of its breakdown products from biological samples. This verification may be important for medical, law-enforcement, military, forensic, research, or veterinary purposes. This review will discuss current bioanalytical techniques used for the verification of cyanide exposure, identify common problems associated with the analysis of cyanide and its biological breakdown products, and briefly address the metabolism and toxicokinetics of cyanide and its breakdown products in biological systems.
INTRODUCTION
Cyanide is toxic to humans and animals and exposure can occur in various ways. Many substances are potential sources of cyanide exposure, including edible and non-edible plants (e.g., cassava), industrial operations (e.g., plastics processing), fires, and cigarette smoke. Although the primary natural source of cyanide poisoning is from plants (1) (2) (3) (4) (5) (6) (7) , other natural sources include volcanoes, bacteria, and fungi (3, (8) (9) (10) (11) (12) . Anthropogenic sources include malfunctioning catalytic converters, fires involving the burning of plastics, cigarette smoke, and illicit uses of cyanide (e.g., terrorist activities) (13) . Additionally, over one million tons of cyanide are manufactured annually worldwide for industrial uses, including chemical syntheses, electroplating, plastics processing, paint manufacturing, gold and silver extraction, tanning, and metallurgy (14) . Along with many legal industrial uses of cyanide, multiple illegal uses of cyanide exist, with terrorist acts garnering the most publicity (15) . For example, in 1982, cyanide was placed in bottles of Tylenol in the Chicago area, killing seven people (16) and in 1995, cyanide was found in several Tokyo subway restrooms in the weeks following the release of the nerve agent sarin (17) . Another illegal can be traced to interference of aerobic metabolism (21, 26, 27) . For mammals, fish, and some invertebrates, this occurs when cyanide blocks terminal electron transfer by binding to cytochrome oxidase. For mammals, cyanide ion (CN − ) is acquired through ingestion, while hydrogen cyanide is acquired through inhalation or absorption through the skin. For fish, cyanide is absorbed through the gills or intestine (18) , but little else is known about cyanide metabolism in fish. Because the majority of research in this area has been done based on human metabolism, the following text summarizes human metabolism of cyanide.
Once absorbed, cyanide is quickly transferred to the blood and metabolized through a number of processes, as shown in Figure 1 . The major pathway for cyanide metabolism is the conversion of cyanide to thiocyanate (SCN − ) in the presence of a sulfur donor (e.g., thiosulfate) (28) . This reaction is catalyzed by the enzyme rhodanese (21, 29) . About 80% of the initial cyanide dose is converted to thiocyanate (30, 31) , which is subsequently excreted in the urine. Other significant metabolic pathways are the conversion of cyanide to 2-amino-2-thiazoline-4-carboxylic acid (ATCA; the tautomeric form of ATCA is 2iminothiazolidine-4-carboxylic acid -ITCA; Figure 1 ) by reaction of cyanide with cystine (21, 29, 32, 33) , and the reversible reaction of cyanide with hydroxocobalamin to form cyanocobalamin. (Note: Throughout the text, the ATCA/ITCA tautomeric pair will be referred to as ATCA.) It is possible that the production of ATCA over thiocyanate may predominate when sulfur donors become depleted, or where rhodanese is sparse. Other minor pathways for cyanide metabolism include the creation of one-carbon metabolites and protein adducts (i.e., reaction of a chemical species with a protein to form a chemical bond that modifies the parent protein) (21, 34) . Each chemical species in Figure 1 could potentially be used as a marker for cyanide exposure.
The toxicokinetics and metabolism of an agent must be considered when an analytical technique is used to determine expo- (30) sure to the agent. If the parent toxic agent metabolizes quickly and immediate analysis of the parent agent is not feasible, an alternative metabolic product which is more stable should be chosen as a target for analysis. One consideration for determining which biomarker to target for confirmation of exposure is the half-life of that biomarker. Table 1 lists the half-lives of cyanide and thiocyanate for acute exposures in a number of mammalian species. The half-life of cyanide is short (t 1/2 = 0.34-1.28 hours), making it difficult to determine exposure to cyanide if significant time has elapsed. Thiocyanate has a longer half-life than cyanide (t 1/2 = 4. 95-192 hours) . The half-lives of ATCA and cyanide-protein adducts have not been evaluated, although for cyanide-protein adducts, a half-life similar to that of the parent protein should be expected for a stable adduct (e.g., 20-25 days for human serum albumin) (35, 36) . Chronic exposure to cyanide increases the apparent half-life of cyanide and thiocyanate (37) (38) (39) (40) (41) . The increase in cyanide half-life is likely due to the depletion of sulfur donors (42) because activity of rhodanese over the course of a long-term exposure does not decrease; in fact, it has been shown to increase (43, 44) . As seen by the half-lives of cyanide in a number of mammalian species in Table 1 , the toxicokinetics of cyanide is, to some extent, species-dependent. Thiocyanate is also speciesdependent, with the estimated half-life of humans being much higher than that of other animals for acute exposures of cyanide (Table 1) . Therefore, care must be taken in extrapolating toxicokinetic and metabolic behavior of cyanide between species.
SPECIAL CONSIDERATIONS FOR THE ANALYSIS OF CYANIDE AND ITS METABOLITES
Multiple factors must be considered when choosing which analyte to target for verification of cyanide exposure. Analysis of cyanide or any one of its metabolites has advantages and disadvantages. Table 2 compares cyanide and its metabolites in terms of some factors important for verification of cyanide exposure.
Considering the half-life of cyanide for acute exposure (Table 1), it would be difficult to determine cyanide  TABLE 2 Comparison of cyanide and its metabolites for verification of cyanide exposure Cyanide/metabolite a Half-lives concentrations from biological samples once significant time has elapsed following exposure. Conversely, direct analysis of cyanide may be the only biomarker capable of indicating exposure to cyanide within the initial minutes following exposure (30, 45, 46) . The issues that limit analysis of cyanide include the rapid cyanide detoxification processes, the difficulty of establishing steady state cyanide levels with time, and the volatility and nucleophilic properties of cyanide (47, 48) . Although traces of cyanide in urine (49) (50) (51) (52) (53) , saliva (54, 55) , and expired air (56-60) have been found, direct analysis of cyanide from these matrices is difficult. Therefore, blood and tissues have been the preferred matrices for cyanide analysis in past studies of cyanide exposure. In tissues, it is difficult to assess rates of cyanide decay in tissues because levels of rhodanese are variable between organs (21) , and because free cyanide concentrations are generally low. Although free cyanide may only be available in low concentrations, cyanide may be bound within tissues. Therefore, the possibility of extracting bound cyanide should be considered prior to conducting a specific cyanide analysis technique. The analysis of the breakdown products of cyanide is a viable alternative to direct analysis. For example, thiocyanate and ATCA have been determined in urine, saliva, tissue, and blood (55, . Cyanide-protein adducts have been found in human blood proteins (34) . The alternative markers of cyanide exposure may be longer-lived (30, 93) and more stable than cyanide (91, 92) . Also, correlation of some of these markers to cyanide exposure has been examined (31, 61, 82, (91) (92) (93) (94) (95) (96) .
The main advantages of analyzing thiocyanate to determine cyanide exposure include the facts that appreciable concentrations of thiocyanate can be found in biological matrices shortly following cyanide exposure and that it has a longer half-life than cyanide (30, 93) . However, thiocyanate is naturally found in biological fluids, and while this is a condition of all cyanide metabolites, thiocyanate levels are relatively high and can be inconsistent (55, (82) (83) (84) (85) (86) (87) (88) . Large variation in background thiocyanate concentrations makes it difficult to determine low-level cyanide exposure. Also, Ballantyne (97) found that concentrations of thiocyanate in blood varied inconsistently during storage at a number of different temperatures and that analytical recovery of thiocyanate from whole blood was difficult. Large and variable concentrations may indicate that thiocyanate is involved in a number of biological processes in addition to cyanide metabolism (28, 98, 99) .
ATCA may be used as an alternative for determination of cyanide exposure. An advantage to using ATCA is that it is stable in biological samples for months at freezing and ambient temperatures (91, 92) . Also, ATCA does not metabolize further (21, 31, 100) and therefore, may be a lasting signature of cyanide exposure. However, relatively few studies have been performed to develop analysis techniques for ATCA from biological matrices (61, (89) (90) (91) (92) or to evaluate the relationship between ATCA and cyanide exposure (61, 91, 92) . It has also been suggested that ATCA is neurotoxic (101, 102) and therefore may contribute to cyanide toxicity. With a greater understanding of its behavior with relation to cyanide exposure, the analysis and characterization of ATCA may prove beneficial.
Recently, cyanide-protein adducts have been discovered (34) . If these adducts are stable, they could serve as long-lived markers of cyanide exposure. Currently, this analysis technique requires costly instrumentation and lengthy sample preparation. Even considering these issues, cyanide adducts are extremely promising for providing a long-lived biomarker of cyanide exposure, especially if a less complex and less costly method of analysis can be developed.
BIOLOGICAL MATRIX CONSIDERATIONS FOR VERIFICATION OF CYANIDE EXPOSURE
Most published methods for determination of cyanide exposure perform the analysis on blood samples. For humans, determination of cyanide exposure has been attempted from blood (34, 37, 45, 49, 51, 55, 59, 82, 95, , urine (49-53, 64, 142) , saliva (54, 55, 64, 70) , expired air (56) (57) (58) (59) (60) , and tissue (post-mortem) (51, 129, 140, 143, 144) samples. Blood may be the most versatile biological sample used to determine exposure to cyanide, because the analyses of cyanide, thiocyanate, ATCA, and cyanide-protein adducts can each be performed on blood samples. Saliva, urine, or tissue may be more appropriate depending on the analytical method and other factors, including ease of obtaining the sample. If determination of cyanide exposure is to be done from non-human species, obviously saliva and urine samples will be difficult to obtain. Therefore, blood and tissues are the most likely samples to be analyzed to determine cyanide exposure. The choice of blood or tissue is determined by a number of factors, including the size of the species. For example, small mice would not have sufficient quantities of blood for some analytical techniques, which makes the analysis of tissue samples indispensable. Another consideration is that rates of cyanide metabolism may be inconsistent between organs because of variable rhodanese and sulfur donor concentrations (21) . Therefore, careful selection of tissue, depending on the analyte to be determined, can be extremely important.
THE DETECTION OF CYANIDE AND ITS METABOLITES IN BIOLOGICAL SAMPLES
The determination of cyanide, thiocyanate, ATCA, and cyanide-protein adducts in biological fluids and tissues is useful for forensic, clinical, research, law enforcement, and veterinary purposes. Methods of analysis include spectrophotometry (37, 59, 62, 74, 78, 81, 89, 90, 93, 105, 120, 130, 133, 139, 141, 143, , fluorescence (49, 51, 89, 115, 121, 132, 142, (175) (176) (177) (178) (179) (180) (181) , chemiluminescence (77, 109) , electrochemistry (18, 56, 63-65, 68, 69, 73, 75, 79, 80, 106, 129, 138, 153, 182-197) , gas chromatography (GC) (45, 53, 54, 61, 91, 95, 103-105, 107, 108, 111, 113, 114, 117, 119, 121, 125, 126, 128, 131, 135, 137, 152, 198-212) , liquid chromatography (LC) (34, 40, 49, 52, 66, 67, 72, 92, 94, 109, 110, 112, 115, 122, 134, 142, 153, 162, (190) (191) (192) (213) (214) (215) (216) (217) (218) (219) (220) (221) (222) (223) (224) (225) (226) (227) (228) , flow injection analysis (FIA) (64, 109, 191, 193, 215) , capillary electrophoresis (CE) (70, 229, 230) , and atomic absorption (AA) (231, 232) . Choosing from the many available types of analytical methods and biomarkers of cyanide exposure, complicated by numerous discrepancies in the literature between these methods, makes selection of an analytical method daunting. Factors that will influence the initial choice of which biomarker and analytical technique to use are cellular absorption and detoxification kinetics, sampling and analysis time, sample storage time and conditions, sample matrix, interferences, sensitivity, available instrumentation and equipment, expertise, and cost. In Table 3 , some differences between methods listed above are presented.
SAMPLE STORAGE AND PREPARATION
Careful sample preparation and storage of biological samples containing cyanide or its metabolites is a key element to producing accurate results. A significant problem in the analysis of cyanide and thiocyanate is their interconversion, which can occur during sample preparation and storage and leads to inaccurate results (82, 233) . The amount of cyanide within the sample can be altered during storage by up to 66% in 14 days, depending on the storage temperature (22, 45, 132, (234) (235) (236) (237) . There are a number of methods to help prevent artificial formation of cyanide during storage, and if samples containing cyanide are to be stored before analysis, methods to prevent cyanide formation should be considered (see Suggested Procedures for Delayed Analysis of Biological Samples section). For example, Seto et al. (121) demonstrated artificial formation of HCN from thiocyanate in blood and later showed that ascorbic acid prevents artifactual cyanide formation at temperatures below 63 • C (234, 238) . Also, Sano et al. (122) found that pre-treatment of blood samples with water and methanol was successful in preventing artifactual formation of cyanide from thiocyanate. The artifactual formation or degradation of ATCA does not appear to be a problem as the stability of ATCA in biological samples under a number of storage conditions has been established (91, 92) .
Earlier methods of cyanide analysis involved extensive sample preparation in which the sample was acidified (typically with sulfuric or phosphoric acid) and HCN was transferred to alkaline solution by distillation or microdiffusion (37, 49, 82, 95, 110, 132, 139, 147, 168, 173, 179, 239) . This served to concentrate the cyanide and to separate it from potential interferences. Buffered hydroxocobalamin (120, 240) or methemoglobin (143) solutions have also been used to capture liberated HCN. This pre-treatment method can be used prior to most analytical techniques for the determination of cyanide and allows the use of analytical techniques that would not normally be useful for biological samples. For example, separation of cyanide by distillation has been used prior to ion-selective electrode (ISE) analysis of cyanide (18) . For GC analysis of HCN, the procedure of liberating HCN by acidification (without capture in solution) is extensively used with headspace analysis (45, 103-105, 108, 119, 121, 125, 128, 135, 137, 152, 198, 200, 203, 204, 206, 207, 241) . Maseda et al. (95) added a pre-column derivatization step to increase the sensitivity of the GC analysis technique. This technique has also been used prior to headspace solid-phase microextraction (SPME) in which liberated HCN was concentrated on a SPME fiber prior to GC analysis (107, 113) . It has also been used in a similar manner for single-drop microextraction (SDME) with in-drop derivatization and subsequent analysis by CE (229) . It should be noted that when using methods that liberate HCN, rubber septa or stoppers can react with gaseous HCN. Therefore, polytetrafluoroethylene septa should be used (48, 95) . (Note: It is always necessary to consider the volatility of HCN when working with samples that may have significant concentrations of cyanide and the dangers that it may pose to laboratory personnel.) Individual pretreatment steps (i.e., derivatizations) are generally necessary for detection of cyanide by spectrophotometry or fluorescence. For example, Lundquist and Sörbo (130) used a modification of the König reaction ( Figure 2 ) for spectrophotometric determination of blood cyanide concentrations by highperformance liquid chromatography (HPLC). Another example is the fluorometric derivatization of cyanide produced from the reaction of cyanide with 2,3-naphthalenedialdehyde (NDA) and taurine ( Figure 3 ). This reaction has been effectively used with HPLC-fluorescence or as a stand-alone fluorescence method to produce highly sensitive methods for the determination of cyanide (49, 50, 110, 112, 115, 122, 134, 142) . The derivatization schemes mentioned will be discussed in more depth below along with other derivatization schemes. Thiocyanate sample preparation normally involves derivatization that is intended to increase a specific detector's response to the ion. While initial sample preparation is not common, ion exchange columns could be used to separate thiocyanate from biological sample components. Thiocyanate is weakly spectrophotometrically active, and therefore is often derivatized with a strong absorber or fluorophore prior to analysis. For example, 3-bromomethyl-7-methoxy-1,4-benzoxazin-2-one has been effectively used (Figure 4 ) for the fluorometric determination of thiocyanate by HPLC (217) . Others have also used variations of the König reaction to produce strong spectrophotometric absorption (157, 162) .
Multiple methods have been proposed for the simultaneous analysis of cyanide and thiocyanate. Methods for simultaneous analysis are generally limited to chromatographic methods which involve derivatization. or thiocyanate in biological samples (111, 205, 208, 209) . LC has also been used for the simultaneous detection of cyanide and thiocyanate. Sample preparation for cyanide-protein adducts involved isolation of the protein of interest with subsequent enzymatic digestion. Fasco et al. (34) used this technique to analyze protein fragments after digestion with trypsin. Although this method was time-consuming and required powerful instrumentation, the authors were able to detect protein-cyanide adducts from the plasma fraction of human blood.
SPECTROPHOTOMETRIC, LUMINESCENCE, AND ATOMIC ABSORPTION METHODS
Early spectrophotometric methods of cyanide analysis from biological fluids were often based on the König synthesis ( Figure 2) (60, 168, 169, 171-174, 179, 239) . König dye synthesis involves oxidation of cyanide using chloramine-T (139, 147, 157, 160) , hypochlorite (130, 133, 176) , or bromine water (59, 165, 172, 173) to form a cyanogen halide. The cyanogen halide is then reacted with an aromatic amine (normally pyridine) to produce an aldehyde product that is spectrophotometrically analyzed in the visible region. These methods have adequate sensitivity, but the products are unstable and they lack specificity due to interferences from other chemical species commonly present during the analysis of cyanide, especially thiocyanate and thiosulfate (175) . Therefore, these methods often require microdiffusion sample preparation. Modifications have been developed that yield more stable reagents and increased precision for this type of reaction (59, 93, 133, 147, (163) (164) (165) (166) .
Spectrophotometric analysis of thiocyanate is often a variation of the König reaction described above. Hypochlorite and thiocyanate react to form the cyanogen chloride, then either pyridine-malononitrile (161) or barbituric acid-pyridine reagent (130, 157, 159, 162) can be used as coupling agents. Cyanogen chloride can also be combined with isonicotinic acid to produce a glutaconic aldehyde. Condensation of this aldehyde with two molecules of 1,3-dimethylbarbituric acid produces a dye which can be analyzed spectrophotometrically (153) . Other early methods of thiocyanate analysis (170) involved oxidation of the thiocyanate to hydrogen cyanide, with aeration into alkaline solution, permitting the determination of cyanide as described above for the König reaction. The modified König reaction was also applied to the simultaneous analysis of cyanide and thiocyanate (52, 134, 172, 173) . Nagashima (160) used the differences in the rates of the reaction of cyanide and thiocyanate with chloramine-T and variations in pH dependence for the simultaneous spectrophotometric determination of cyanide and thiocyanate.
ATCA has also been analyzed spectrophotometrically. Bradham et al. (89) analyzed ATCA from urine as described previously. Limitations for this method include interference from a number of species (including cyanide ions) and lengthy sample preparation.
Fluorescence (49, 51, 115, 132, (175) (176) (177) (178) 181) methods have been applied to the determination of cyanide in biological fluids. As with spectrophotometric methods, fluorescence methods normally require extraction techniques to isolate cyanide and eliminate interferences. A number of sensitive fluorometric assays to determine cyanide, free of thiosulfate interference, have been developed with greater sensitivity than spectrophotometric methods (51, 176, 177) . One specific fluorometric method for the analysis of cyanide is the reaction of cyanide with NDA and taurine to create a highly fluorescent isoindole ( Figure 3 ) (49, 115) . A chemiluminescence method has also been developed for the analysis of cyanide from whole blood (109) . For this method, acidification and distillation was used to separate cyanide from interfering whole blood components and a microchip-based reactor was used to mix sample preparation reagents and produce chemiluminescence.
Although non-chromatographic fluorescence methods for the determination of thiocyanate, ATCA, or cyanide-protein adducts have not been published, the possibility exists to use such methods for ATCA and thiocyanate. For instance, 3-bromomethyl-7methoxy-1,4-benzoxazin-2-one ( Figure 4 ) and coumarin dyes have been used effectively for the HPLC-fluorometric determination of thiocyanate (217) and ATCA (92), respectively.
AA methods are indirect methods of cyanide or thiocyanate analysis. A metal complex is formed with the thiocyanate or cyanide which subsequently precipitates or is extracted into an organic solvent. This metal complex is then analyzed by AA spectrometry. For example, cyanide has been analyzed indirectly by complexing with an iron(II)-phenanthroline, extracting in chloroform, analyzing iron by AA, and directly relating the iron concentration to the cyanide concentration (242) . Chattaraj and Das (232) used AA spectrometry for the analysis of thiocyanate in biological fluids by forming a complex with thiocyanate and copper and determining the copper signal. This technique has not been used to determine ATCA or cyanide-protein adducts.
ELECTROCHEMICAL, ION-SELECTIVE ELECTRODE, AND BIOSENSOR METHODS
Many electrochemical methods for the detection of cyanide and thiocyanate exist, but relatively few of these methods have been applied to their analysis in biological samples (18, 56, 63-65, 68, 69, 73, 75, 79, 80, 106, 129, 138, 153, 182-197, 199, 243) . The benefits of using electrochemical methods are high sensitivity and quick analysis time. However, they can be subject to multiple interferences from many organic and inorganic ions, including S 2− , ClO − 4 , NO − 2 , N − 3 , and I − (129, 188) . Electrochemical methods can also be hampered by narrow working concentration ranges and may require large sample sizes (185, 187) . Westley and Westley (129) used a silver rotating disk electrode and a dropping mercury electrode for the voltammetric determination of cyanide and thiocyanate in biological samples, including plasma, tissue, and whole blood. Electrochemical detection can also used with ion chromatography for the analysis of cyanide and thiocyanate (190) .
Polymeric membrane-based ISEs have been developed to address some of the issues limiting electrochemical analysis of cyanide and thiocyanate (23, 64, 65, 69, 73, 75, 79, 80, 106, 182-184, 186-189, 194, 243-245) . ISEs can exhibit rapid response, high sensitivity, wide linear range, low cost, and they are usually simple to operate. The polymeric membrane in ISEs contains an ion carrier that interacts selectively with the analyte. This interaction is often enhanced by the use of a metal in the ion carrier that strongly interacts with the analyte ion. Although many ISEs exist, they are somewhat limited for anions compared with cations (188) . ISEs have been developed for cyanide analysis, but few have been used for analysis of cyanide from biological samples. This is due to the interaction of multiple ions and biological materials present in biological samples. If these interferences can be removed, then ISE methods could be used for the determination of cyanide from biological samples. In fact, the standard method for the analysis of cyanide from fish tissues is based on an ISE (245) . For this method, tissue samples are prepared by homogenizing, acidifying, and distilling internal organs of fish species. Cyanide present in the homogenized tissue is converted to HCN and captured in an alkaline solution following distillation. A cyanide ISE is then used to analyze for cyanide based on its interaction with silver. Another ISE test using gold disc electrodes coated with a sulfonated tetrafluoroethylene copolymer was recently developed by Lindsay and O'Hare for the analysis of cyanide in blood without sample pre-treatment (106) .
Thiocyanate, due to its lipophilicity, is well-suited for ISE analysis and has been successfully analyzed by ISEs (23) . ISEs have been developed that exhibit good agreement with ion chromatography (194) and spectrophotometry (186) (187) (188) (189) , and have been used to analyze thiocyanate from plasma (194) , urine (64, 65, 68, 69, 73, 79, 80, 184, (186) (187) (188) (189) 243) , and saliva (64, 66, 68, 69, 73, 79, 80, 182, 183, (186) (187) (188) . For example, ISEs based on crystal violet or methylene blue and a selective polymeric membrane containing a nickel(II)-azamacrocycle complex showed excellent selectivity and sensitivity and were successfully used for the analysis of thiocyanate in urine and saliva (187, 194) . Other electrodes which have shown good selectivity for thiocyanate in biological samples include a polyvinyl chloride (PVC) membrane electrode based on a nickel-hexaazacyclotetradecane derivative (186), a PVC membrane electrode with an unsymmetrical nickel(II) macrocyclic complex as an ion carrier (188) , and a graphite electrode based on iron phthalocyanine membranes (189) .
Many biosensors (small detection devices normally based on biological activity toward an analyte) exist for the determination of cyanide, including microbial cyanide sensors, sensors based on the enzyme inhibition of cyanide, and sensors based on cyanide degrading enzymes. Most biosensors have the advantage of being portable, inexpensive, easy to use, and can have high selectivity. Limitations of biosensors include degradation of biological components that make up these sensors, inconsistent electrochemical signals, and difficulty producing sufficient quantities and activities of enzymes or microorganisms on which these sensors depend. Most of the biosensors developed for cyanide analysis have not been applied to the analysis of biological samples, although a biosensor system for the determination of cyanide in fish was recently described (146) . For this method, cyanide hydrolase was used to convert cyanide into formate and ammonia. The formate was detected and converted to CO 2 with a formate biosensor, which produced NADH from NAD+. A Clark electrode was used to monitor the consumption of oxygen from the oxidation of NADH back to NAD+ (18) .
Currently, biosensors have not been applied to thiocyanate detection from biological samples. Also, electrochemical and biosensor methods have not been used to analyze for ATCA and cyanide-protein adducts from biological samples.
LIQUID CHROMATOGRAPHY, CAPILLARY ELECTROPHORESIS, AND FLOW INJECTION ANALYSIS
The complex nature of biological matrices, the small concentrations of cyanide and its metabolites, and the high number of species that interfere with spectrophotometric, luminescent, and electrochemical methods have often necessitated analysis of cyanide and its metabolites by more powerful methods. LC techniques can determine trace amounts of an analyte and can efficiently separate analytes from interfering components in the matrix. Chromatographic techniques, both liquid and gas, also have the ability to simultaneously analyze for cyanide and thiocyanate. For these reasons, LC methods have gained popularity in analysis of cyanide and its markers in biological samples.
Two types of LC have been used to analyze cyanide: reversephase high-performance liquid chromatography (RP-HPLC) (34, 40, 50, 52, 92, 94, 110, 115, 122, 134, 142, 217, 221, 225, 228) and ion chromatography (IC) (112, 162, 190-192, 213, 216, 218-220, 222-224, 226) . RP-HPLC methods are common, but generally require pre-treatment steps for each anion or multiple post-column reagents. IC methods are common for thiocyanate analysis but cyanide is not normally analyzed with this technique. Some common detectors used in the LC analysis of cyanide or its metabolites include spectrophotometric (52, 72, 94, 153, 162, 223) , fluorescence (40, 49, 115, 122, 134, 142, 217, 225) , electrochemical (193, 215, 219, 228) , and MS (34, 110) detection. CE (230) is a related method of analysis that involves initial separation of a sample and subsequent analysis.
Several groups have adapted the spectrophotometric detection of cyanide and thiocyanate in blood and urine based on the König reaction ( Figure 2 ) to RP-HPLC (153, 162, 223, 227) . This reaction has also been used for HPLC with fluorometric detection. Toida et al. (134) analyzed cyanide in blood at picomole levels with HPLC and fluorometric detection by using a variant of the König reaction, replacing pyridine with pyridinebarbituric acid. Fluorescence detection was also used for the determination of cyanide in human erythrocytes, whole blood, and urine using RP-HPLC and pre-column derivatization with NDA and taurine ( Figure 3) (50, 122) . A number of other fluorometric HPLC methods have been developed for the analysis of cyanide and its metabolites from biological fluids (112, 115, 217, 225) .
Detection of thiocyanate and simultaneous detection of cyanide and thiocyanate have been accomplished using RP-HPLC with fluorometric detection. Tanabe A limited number of IC methods have been developed for analysis of cyanide (112) . Conversely, multiple IC methods have been used to analyze biological fluids for thiocyanate (72, 112, 162, 190-192, 213, 216, 218-220, 222-224, 226) . Chinaka et al. (112) used NDA derivatization of cyanide with an ion exchange column for the simultaneous determination of cyanide and thiocyanate. Lundquist et al. (162) used an ion exchange column with visible spectrophotometric detection for the determination of thiocyanate in serum and urine. Connolly et al. (213) used ion interaction LC with UV detection to analyze thiocyanate in urine. ISEs have also been used to detect thiocyanate in urine following IC (190) .
Another type of LC that involves both RP and ionic interactions is called ion-pairing chromatography. With ion-pairing chromatography a column modifier is added to the mobile phase to create an ionic stationary phase. Authors using this type of chromatography have coated RP-HPLC columns with ion-pairing agents to mainly analyze thiocyanate. Examples of this type of analysis include RP-HPLC columns coated with cetyldimethylamine (222, 224), a zwitterionic micelle (192) , and bovine serum albumin (216) . Brown et al. (40) used a cetylpyridinium coated RP column to create an ion-exchange column for the analysis of thiocyanate from rainbow trout plasma in a pharmacokinetic study of thiocyanate exposure.
CE and FIA are not chromatographic methods because they do not utilize a stationary phase but they are similar in that small precise volumes of sample are added to a continuously flowing carrier stream. Moreover, CE is also used to separate the components of a sample prior to detection and both CE and FIA normally use LC detectors. CE has been used successfully for the analysis of cyanide (229) and thiocyanate (70, 230) in biological fluids. Glatz et al. (230) analyzed blood, urine, and saliva samples for thiocyanate with CE and spectrophotometric detection, with no sample preparation aside from dilution. Jermak et al. (229) used CE for determination of cyanide after headspace SDME with in-drop derivatization. CE methods for cyanide, ATCA, and cyanide-protein adducts have not been suggested. A number of FIA methods have been proposed to analyze for cyanide biomarkers in biological samples (64, 109, 191, 193, 215) . For example, Cookeas and Efstathiou (193) successfully determined thiocyanate in saliva with FIA and ISE detection using a cobalt-phthalocyanine modified carbon paste electrode.
GAS CHROMATOGRAPHY
One of the most common methods for analysis of cyanide, thiocyanate, and more recently ATCA is gas chromatography. Common detectors used for analysis of cyanide or its metabolites are the electron capture detector (ECD) (95, 103, 119, 125, 128, 200, 205, 211, 212, 241, 246) , nitrogen-phosphorus detector (NPD) (45, 53, 65, 105, 113, 114, 117, 121, 126, 131, 135, 137, 152, 202, (207) (208) (209) , and MS detector (61, 91, 107, 108, 111, 117, 199, 210) . Although most of these methods are used for detection of cyanide in blood, some groups have applied GC techniques for other biological matrices and for the detection of thiocyanate and ATCA.
For the detection of cyanide from biological matrices, no specific derivatization is necessary as HCN is volatile. Therefore, the most common pre-analysis step in GC analysis of cyanide is sampling of cyanide from the sampling of the headspace following acidification of the sample. Either equilibrium or dynamic headspace methods can be used to prepare a sample for GC analysis (45, 103-105, 108, 113, 119, 121, 125, 128, 135, 137, 152, 199, 203, 204, 206, 207, 241) . Another pre-analysis step for cyanide analysis is cryogenic oven trapping, which has been used to trap liberated HCN and produce high resolution and sensitivity (114, 202) . Because thiocyanate and ATCA are non-volatile, they require chemical modification (i.e., derivatization) to allow analysis by GC. Also, chemical modification is necessary for analysis of cyanide by ECD (because of its poor response to underivatized cyanide) or for simultaneous analysis of cyanide and thiocyanate. Therefore, a number of pre-treatment steps have been developed to facilitate the analysis of cyanide, thiocyanate, and ATCA by GC.
In GC analysis, the NPD permits the sensitive and specific detection of nitrogen-or phosphorous-containing compounds, and has been used for the detection of cyanide and thiocyanate in blood, plasma, urine, and saliva (45, 53, 105, 113, 114, 117, 121, 126, 131, 135, 137, 152, 198, 202, (207) (208) (209) . However, this detector may be unstable at times, and is less sensitive than some other types of GC detectors. This has led to the creation of analytical methods that take advantage of more stable and sensitive detectors such as the ECD and MS. PFBBr is most commonly used for the derivatization of cyanide, especially for ECD detection (117, 118, 247, 248) . The conversion of HCN into cyanogen chloride by choramine-T oxidation (Figure 2) has also been used for GC-ECD analysis (95, 103, 119, 212) .
One of the most sensitive methods for analysis of cyanide, thiocyanate, and ATCA is GC-MS (54, 61, 91, 107, 108, 111, 199, 201, 203, 210) . With MS detection, stable isotope internal standards (e.g., 13 CN, C 15 N, or 13 C 15 N) can be used to correct for matrix effects common to cyanide and cyanide metabolites. This can eliminate the need for standard addition techniques and matrix matching. Murphy et al. (199) and Dumas et al. (108) used a stable isotope internal standard with GC-MS and head space analysis to analyze cyanide concentrations from blood. GC-MS has also been used to analyze cyanide and thiocyanate simultaneously (54, 117) . Logue et al. (61, 91) analyzed ATCA by GC-MS in plasma and urine by first converting the non-volatile metabolite into a volatile form using trimethylsilyltrifluoroacetamide. Cyanide-protein adducts have not been analyzed by GC-MS.
SUGGESTED PROCEDURES FOR DELAYED ANALYSIS OF BIOLOGICAL SAMPLES
As discussed earlier, because of the rapid detoxification of cyanide from blood samples, a sample for cyanide analysis should be collected quickly after exposure and analysis should be performed as soon as possible. However, if analysis of cyanide cannot be performed quickly and storage of biological samples is necessary, the following should be considered:
Volatility and nucleophilicity of cyanide. HCN is volatile
and the cyanide ion is nucleophilic. Tightly sealed vials, low temperatures, high pH (i.e., pH > 10.5), and the addition of preserving agents are common procedures that have been used to prevent loss of cyanide. Storing samples at low temperatures is extremely important to reduce evaporative loss and slow biochemical reactions. However, there are many discrepancies in the literature when evaluating the stability of cyanide in biological fluids under various conditions (82, 133, 175, 237, 249) . Generally, nucleophilic losses are reduced by adding sequestering agents (e.g., hydroxocobalamin) or chemicals that produce sequestering agents (e.g. sodium nitrite to produce methemoglobin) (130, 133, 250) . One method found to improve cyanide stability is the addition of silver ions to biological samples (133).
Cyanide concentration varies in biological components.
Cyanide in blood primarily resides in erythrocytes (red blood cells) (48, 133, 139, 236, 251) by binding to methemoglobin, forming cyanomethemoglobin. Cyanide may also be present in plasma, especially if cyanide concentrations exceed hemoglobin concentrations (133, 139) . To ensure accurate cyanide concentrations when analyzing blood, collection containers that contain anti-coagulants (e.g., heparin) should be used to prevent clotting, and analysis of whole blood or both plasma and red blood cells should be performed. Analysis of cyanide from tissues requires knowledge of the behavior of cyanide in specific organs since the enzyme that catalyzes conversion of cyanide to thiocyanate has highly variable concentrations depending on the organ. Therefore, in specific organs, there will be little to no cyanide because of extremely fast metabolism to thiocyanate. 3. Potential for cyanide formation during storage. Artifactual formation of cyanide may also occur in biological samples depending on storage conditions (132, (235) (236) (237) . It has been suggested that oxyhemoglobin (234), thiocyanate oxidase (235, 236) , and white blood cells (132) may oxidize thiocyanate to cyanide and these reactions are dependent on the temperature and pH of the sample. Microorganisms may also be responsible for cyanide production and low temperature storage will help to eliminate their growth (235) .
These considerations are common to all the analytical methods for analysis of cyanide from biological samples and certainly contribute to discrepancies in similar studies in the literature. Additionally, production and transformation of cyanide must be considered when interpreting results for post-mortem cyanide analysis (140, (252) (253) (254) (255) .
Some of the same issues must also be considered for thiocyanate, as a number of problems with storage of thiocyanate samples have been found (97) . This may be due to the interconversion of thiocyanate and cyanide over time and the removal and production of thiocyanate by biological processes other than Blood 0.518 ± 0.037 (7) 0.597 ± 0.062 (6) IC-FLD (112) Whole blood 2.1 (6) 6.6 (11) GC-ECD (136) Whole blood 0.13 ± 0.08 (10) 0.33 ± 0.12 (5) UV-Vis (133) Whole blood 0.24 ± 0.22 (10) 0.68 ± 0.20 (5) UV-Vis (133) Red blood cells 0.02 ± 0.02 (10) 0.03 ± 0.02 (5) UV-Vis (133) Plasma 1.2 (10)
1.8 (10) UV-Vis (259) Whole blood 0.098 ± 0.036 (8) 0.125 ± 0.035 (5) Fluorescence (132) Whole blood; study separated by time post-smoking; concentration reported here is referred to as "basal" 0.14 ± 0.01 (3) 0.35 ± 0.09 (4) RP-HPLC-FLD (134) Red blood cells 0.466 ± 0.072 (10) 0.705± 0.112 (10) RP-HPLC-FLD (122) Red blood cells Not detected (5) 0.058 ± 0.030 (5) Fluorescence (49) Whole blood 0.02 (1) 0.06 ± 0.03 (5) IC-ED (49) Whole blood; only one value reported above detection limit for non-smokers 0.59 ± 0.23 (10) 1.5 ± 0.6 (14) UV-Vis ( (20) 0.66 ± 0.52 (20) GC-NPD
a See method notes in Table 3 . b Excluded Pettigrew and Fell (82) because concentrations of cyanide in smoker blood were below non-smoker blood and relative errors were very large. c The term "plasma" refers to serum or plasma.
cyanide detoxification (28, 99) . It has been suggested that ATCA is not involved in other biological processes and has been found to be stable during storage (21, 31, 91, 92, 100) . While ATCA may not have the storage issues of cyanide and thiocyanate, there is little known about its toxicokinetics, which currently limits its use as a biomarker for cyanide exposure. Cyanide-protein adducts have only recently been discovered. Therefore, little is known about the toxicokinetics and stability of these adducts, and only one analytical technique has been developed to analyze these adducts (34) . Table 3 . b The term "plasma" refers to serum or plasma.
ENDOGENOUS CONCENTRATIONS OF CYANIDE AND ITS BREAKDOWN PRODUCTS
When analyzing for cyanide exposure, it is important to note that all biological samples will contain endogenous levels of cyanide (and its biological markers). Therefore, baseline levels of the analyte (cyanide, thiocyanate, ATCA, or cyanide-protein adducts) should be known prior to concluding the occurrence of a cyanide exposure. Table 4 lists reported endogenous concentrations of cyanide in various biological samples from human smokers and non-smokers. Tables 5 and 6 report similar information for thiocyanate and ATCA, respectively (no information is available for cyanide-protein adducts). The concentrations listed give an idea of background concentrations of cyanide and its breakdown products that may be encountered when determining cyanide exposure. Tables 4-6 ). The figures also contain the intra-study concentration ratios of smokers and non-smokers (e.g., the ratio of the mean cyanide concentration in the urine of smokers to the mean cyanide concentration in the urine of non-smokers in a specific study). Table 3 . b The term "plasma" refers to serum or plasma.
First, it is apparent that for cyanide and thiocyanate, the endogenous concentrations for smokers and non-smokers are inconsistent between studies. This may be due to variations in method robustness, differences in the environment or diet of the study populations used, or difficulties in delayed analysis of cyanide biomarkers addressed above. Inconsistent endogenous concentrations make it difficult to determine cyanide exposure from biological fluids. As seen in Figure 5 , blood cyanide concentrations are especially inconsistent, most likely because of differences in storage conditions. For urine cyanide concentrations, most of the smoker concentrations are higher than the Table 4 .
non-smoker concentrations, although there are not enough data to establish the consistency of that relationship. Also, there are not enough data to establish the consistency of cyanide concentrations from saliva. It is important to note that cyanide mainly resides in the red blood cells, so it would be expected that plasma cyanide concentrations reported would be relatively low. Lundquist et al. (133) reported plasma cyanide concentrations of 0.02 and 0.03 µM for smokers and nonsmokers, respectively. These concentrations are two of the lowest in Figure 5 , but even if these values were removed, inconsistency in blood cyanide concentrations would remain evident. For thiocyanate, Table 5 . Table 6 .
there are a large number of studies that report concentrations for each of the biological matrices ( Figure 6 ). From the figure, it appears that plasma offers the best differentiation between thiocyanate concentrations found from smokers and non-smokers. While there is more overlap for both urine and saliva thiocyanate concentrations, the majority of smoker concentrations are above non-smoker concentrations. For ATCA, there is not enough data to derive any conclusions about the consistency of the concentrations in these fluids. Although, for urine, both of the mean concentrations found for ATCA in smokers are higher than those found for non-smokers. It should be noted that the error in urinary analysis of ATCA by GCMS was very large ( Table 6 ) and that a number of individual concentrations for smokers and non-smokers overlapped (91) . Therefore, urinary endogenous concentrations of ATCA between studies would be expected to be inconsistent as well. Plasma ATCA analysis of individual smokers and non-smokers was found to be more consistent than urinary analysis (61) . Concentration ratios of smoker to non-smoker are also plotted for cyanide, thiocyanate, and ATCA. While the absolute blood concentrations of cyanide are inconsistent, the intra-study concentration ratios are relatively consistent, ranging from 1.2-3.1. For urine and saliva, these ratios range from 1.5-5.6 for urine and 1.7 for saliva. Overall, these ratios range from 1.2-5.6, and give an indication that the relative ratios of cyanide found in smokers and non-smokers are quite consistent, even if the absolute concentrations are inconsistent. This provides further evidence that the variability in absolute concentrations for cyanide is an artifact of storage conditions (i.e., time and temperature) and differences in the accuracy of cyanide analysis methods. While the analysis of cyanide concentrations by different methods may contribute to the variability of endogenous concentrations of cyanide reported, Sano et al. (49) found that cyanide concentrations in whole blood for smokers were consistent when comparing IC and fluorescence methods. This example indicates that the major factors contributing to inconsistent cyanide concentrations are associated with storage conditions. For thiocyanate, the intra-study ratios are inconsistent, with ranges of 1.7-7.1, 1.1-44, and 1.1-30 for blood, urine, and saliva, respectively. Each of these ranges is larger than those found for cyanide. This may indicate that thiocyanate is produced or depleted by processes other than cyanide exposure. For ATCA, there is limited data, but it appears that the intra-study ratios (1.5 for plasma and 2.7 for urine) are in good agreement with the ratios found for cyanide. This may indicate that ATCA is produced mainly from cyanide exposure and little is used or produced in other biological processes.
CONCLUSIONS
The analytical determination of biological markers of cyanide exposure is not an easy task due to chemical properties, biological activities, and limited published research (for certain markers of cyanide exposure). Numerous methods have been developed and each has its own advantages and disadvantages. However, they have all provided insight into the verification of cyanide exposure from analysis of biological samples. Table 3 provides a comparison of analytical techniques for analysis of cyanide or its metabolites based on sensitivity, specificity, sample size, capacity, expertise necessary to perform the method, and cost. Some other key pieces of information should also be considered prior to choosing a method to perform:
1. Was preservation of cyanide and its metabolites during storage addressed? 2. Were typical interferences for the biological matrix of interest removed? 3. Were analysis procedures that could result in the loss of cyanide or its metabolites used (i.e., heating or acidification)?
For the analysis of cyanide, the largest inconsistency in the literature is analysis with different preservation techniques. For cyanide analysis, biological samples should be collected and analyzed as soon as possible and regardless of the analytical method, a preserving technique needs to be considered so that accurate concentrations of cyanide can be found (130, 133, 150, 181, (254) (255) (256) (257) (258) . It should also be considered that all biological samples will contain endogenous levels of cyanide (and its biological markers). Therefore, baseline levels of the analyte measured should be known prior to concluding occurrence of a cyanide exposure. Problems with direct analysis of cyanide, including short half-lives, artifactual formation of cyanide, and interconversion of cyanide and thiocyanate, contribute to difficulties in the analysis of cyanide for all analytical methods designed to determine cyanide in biological samples.
While cyanide is most often analyzed to determine cyanide exposure, analytical techniques that analyze for breakdown products of cyanide as well as those that analyze for cyanide directly should be considered. Although cyanide metabolites may offer longer half-lives, they also have a number of drawbacks. For thiocyanate, the main drawback is large and variable background concentrations in biological samples. Other disadvantages include the conversion of cyanide and thiocyanate and the use of thiocyanate by other biological processes not directly related to cyanide metabolism. For ATCA and cyanide-protein adducts, the main drawback is the limited amount of research available on toxicokinetics and relationships of these metabolites to cyanide exposure. Care should be taken when choosing an analytical method to consider not just the parameters of the analytical method but also the toxicokinetics of cyanide and its metabolites.
